Crossmark

Defining FDA Approved Treatments as Reasonable and Necessary: Perspectives of Individuals Living with Alzheimer's Disease and Care Partners

Crossref DOI link: https://doi.org/10.14283/jpad.2023.75

Published Print: 2023-09

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Carrillo, M.C.

Moreno, M.
License Information

Text and Data Mining valid from 2023-09-01

Text and Data Mining valid from 2023-09-01

Version of Record valid from 2024-09-20
More Information

This article is maintained by: Elsevier

Article Title: Defining FDA Approved Treatments as Reasonable and Necessary: Perspectives of Individuals Living with Alzheimer's Disease and Care Partners

Journal Title: The Journal of Prevention of Alzheimer's Disease

CrossRef DOI link to publisher maintained version: https://doi.org/10.14283/jpad.2023.75

Content Type: article

Copyright: Copyright © 2023 THE AUTHORS. Published by Elsevier Masson SAS on behalf of SERDI Publisher. Published by Elsevier Masson SAS